Viewing Study NCT04448561


Ignite Creation Date: 2025-12-24 @ 11:50 AM
Ignite Modification Date: 2026-03-30 @ 4:41 AM
Study NCT ID: NCT04448561
Status: COMPLETED
Last Update Posted: 2024-11-21
First Post: 2020-06-24
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study to Assess the Safety, Tolerability and Pharmacokinetics of Multiple Doses of ASP8062 With a Single Dose of Morphine in Recreational Opioid Using Participants
Sponsor: Astellas Pharma Global Development, Inc.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: 8062-CL-2002
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None NIH View